Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0000899243-20-030330

See Remarks acquired 133,004 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Corcoran Andrea See Remarks 2020-11-03 Conversion +133,004 633,004 D
Derivatives
Corcoran Andrea See Remarks 2020-11-03 Conversion · Series A Convertible Preferred Stock −100,000 0 D
Corcoran Andrea See Remarks 2020-11-03 Conversion · Series B Convertible Preferred Stock −33,004 0 D
Loading xslF345X03/doc4.xml…